Does Finerenone Improve CV Outcomes in Patients with Type 2 Diabetes and CKD? &nbs p;
| | | To ensure that you never miss an issue, please whitelist us. |
|
|
| | A recent cohort study looked at the risk of diabetic ketoacidosis (DKA) and all-cause mortality in patients with T1DM and an eating disorder. A study sample consisting of adolescents and young adults from the ages of 10-39 was collected from the Ontario Diabetes Database in January 2014 and followed for six years. |
|
|
TheFIGARO-DKD trial is an international, multicenter, phase 3, randomized, placebo-controlled, double-blind, event-driven clinical trial, in which 7,437 adults (≥18 years old) patients with T2D and Stage 1-4 CKD treated with either ACE-R or ACB at the maximum dose and having serum potassium level of 4.8mmol/L or less at the time of screening were randomized from September 2015 through October 2018. |
| | |
| |
| |
Chronic diabetic foot ulcers (DFUs) account for around 80% of lower limb amputations, resulting in effective medical treatment and cost burdens. Currently, the treatment for DFUs concentrates mainly on local wound care, which consists of debridement, offloading, controlling infection, and preserving a moist setting with dressings. A new treatment is on its way providing superior results for the patients suffering from diabetic foot ulcers. |
| | |
|
|
|
